Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Hunter Heidi | 0001891841 | Aug-11-2023 | director |
Vivo Opportunity, LLC | 0001728970 | Aug-09-2023 | 10 percent owner |
Smith Devin Whittemore | 0001747818 | Aug-09-2023 | officer: General Counsel |
Vivo Opportunity Fund Holdings, L.P. | 0001930214 | Aug-09-2023 | 10 percent owner |
Kurma Partners | 0001989692 | Aug-09-2023 | 10 percent owner |
Ahmad Qasim Iftikhar | 0001985801 | Jul-15-2023 | officer: Chief Medical Officer |
Sullivan Amy | 0001887865 | Mar-17-2023 | officer: Chief Financial Officer |
Burkavage Brian | 0001865633 | May-11-2022 | officer: Chief Accounting Officer |
Smith David V | 0001229447 | Mar-01-2022 | director |
HBM Healthcare Investments (Cayman) Ltd. | 0001232258 | Nov-04-2021 | 10 percent owner |
Novo Holdings A/S | 0001388325 | Nov-04-2021 | 10 percent owner |
Lundbeckfond Invest A/S | 0001591046 | Nov-04-2021 | 10 percent owner |
Nielsen Jack | 0001602402 | Nov-04-2021 | director |
Glaub Kathleen Sereda | 0001619612 | Nov-04-2021 | director |
Vendola Keith A. | 0001740994 | Nov-04-2021 | officer: Chief Financial Officer |
Vivo Capital Fund IX, L.P. | 0001750117 | Nov-04-2021 | 10 percent owner |
Vivo Capital IX, LLC | 0001750698 | Nov-04-2021 | 10 percent owner |
Hirth Peter | 0001813780 | Nov-04-2021 | director |
Belawat Priyanka | 0001816209 | Nov-04-2021 | director |
Andersson Claus A. | 0001890710 | Nov-04-2021 | director |
Zocca Mai-Britt | 0001890736 | Nov-04-2021 | director, officer: Chief Executive Officer |
Elling Christian E | 0001891306 | Nov-04-2021 | director |
Ehrnrooth Eva | 0001891333 | Nov-04-2021 | officer: Chief Medical Officer |
Coutanceau Emmanuelle | 0001891499 | Nov-04-2021 | director |
Malier Vanessa | 0001891515 | Nov-04-2021 | director |
Al-Hajj Muhammad | 0001892300 | Nov-04-2021 | officer: Chief Scientific Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by IO Biotech, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
8-K | Document | Current report filing Acc-no: 0001193125-24-118498 (34 Act) Size: 139 KB |
Apr-26-2024 | 24885431 |
ARS | Document | Annual report to security holders Acc-no: 0001193125-24-110078 (34 Act) Size: 3343 KB |
Apr-24-2024 | 24870608 |
DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001193125-24-110070 (34 Act) Size: 561 KB |
Apr-24-2024 | 24870587 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001193125-24-110057 (34 Act) Size: 975 KB |
Apr-24-2024 | 24870565 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001193125-24-075426 (34 Act) Size: 269 KB |
Mar-22-2024 | 24776126 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000970 ( Act) Size: 5 KB |
Mar-18-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000969 ( Act) Size: 5 KB |
Mar-18-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000968 ( Act) Size: 5 KB |
Mar-18-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000967 ( Act) Size: 5 KB |
Mar-18-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000966 ( Act) Size: 5 KB |
Mar-18-2024 | |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-064912 (33 Act) Size: 88 KB |
Mar-11-2024 | 24738897 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-24-026275 (34 Act) Size: 14305 KB |
Mar-05-2024 | 24722300 |
8-K | Document | Current report filing Acc-no: 0001193125-24-059364 (34 Act) Size: 245 KB |
Mar-05-2024 | 24721569 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902664-24-001586 (34 Act) Size: 56 KB |
Feb-14-2024 | 24632818 |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-24-034462 (34 Act) Size: 67 KB |
Feb-13-2024 | 24631605 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-003303 ( Act) Size: 5 KB |
Feb-13-2024 | |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000070858-24-000110 (34 Act) Size: 93 KB |
Feb-13-2024 | 24631189 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000935836-24-000138 (34 Act) Size: 58 KB |
Feb-13-2024 | 24626492 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-019876 (34 Act) Size: 36 KB |
Feb-13-2024 | 24625813 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0002006194-24-000002 (33 Act) Size: 4 KB |
Feb-09-2024 | 24617159 |
Recent 20 filings. View all IO Biotech, Inc. filings
Huge help thank you for your help .. y'all make it so much easier
Thanks I look forward to using the product to improve my skin tone
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by